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Background: Our prior laboratory work has permitted adding a whole donor heart to
a preserved recipient right heart, producing a heart-and-a-half preparation able to
cope with pulmonary hypertension in the recipient. The experiments in the present
study explore the feasibility of the converse operation: adding an isolated donor
right heart to an entire preserved heart.
Methods: Eight adult mongrel dogs (4 donors and 4 recipients) were used in 4
transplant operations performed through a right thoracotomy without cardiopulmo-
nary bypass (using side-biting control of recipient vessels). The donor heart under-
went resection of the left atrium and left ventricle, leaving an isolated donor right
heart. Blood supply to the donor right ventricle was preserved from the donor
ascending aorta. Through a right thoracotomy, the donor right heart was trans-
planted in parallel to the native right heart of the recipient by using the following
anastomoses: (1) donor superior vena cava to recipient superior vena cava (end-to-
side anastomosis); (2) donor pulmonary artery to recipient pulmonary artery (end-
to-side anastomosis); (3) donor ascending aorta to recipient aorta (through a great
vessel [end-to-end anastomosis] to provide arterial inflow to donor coronary arter-
ies). Animals were euthanized within 1 hour after completion of transplantation.
Results: Isolation of the right ventricle by excision of the left chambers was
technically feasible. Transplantation without cardiopulmonary bypass was feasible
in all cases. The isolated right heart beat well after transplantation in all animals,
demonstrating sinus rhythm. Three of 4 animals were able to sustain good hemo-
dynamics on support with epinephrine. Bleeding from the septum or aortic valve of
the donor (now open to the pericardial space) was not problematic. Mean arterial
pressure was 85 mm Hg (mean) at a right atrial pressure of 6 mm Hg (mean). In 2
animals the recipient superior vena cava was ligated to obligate upper body flow to
pass through the accessory ventricle; hemodynamics were preserved under these
circumstances.
Conclusion: Transplantation of an isolated right heart is feasible. Such a technique
has potential as a novel therapeutic alternative for obstructive or hypoplastic lesions
of the right heart in human children.
Prior work in our laboratories has demonstrated the feasibility ofpreserving the recipient right heart while transplanting an entire donorheart, resulting in a one-and-a-half-heart preparation.1 That work wasmotivated by the goal of preserving the native right heart as a naturalassist for the donor right heart in combating pulmonary hypertensionin recipients. The effectiveness of this model against iatrogenic pul-
monary hypertension has recently been demonstrated in our laboratories.2
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Having thus achieved the separation of the right and left
sides of the heart, we decided to explore the converse
operation: adding a donor right heart to a preserved com-
plete recipient heart. This technique, if feasible, could pro-
vide a novel alternative treatment for congenital hypoplastic
lesions of the right heart.
The experimental work presented here explores the fea-
sibility of this converse operation: transplantation of an
isolated right heart to supplement a preserved recipient
heart.
Methods
After review by the Yale University Institutional Animal Care and
Use Committee, surgical experiments were performed on 8 mon-
grel dogs weighing 35 to 40 kg. Four dogs served as donors, and
4 were recipients. Side-by-side operating tables allowed the donor
and recipient operations to be carried out simultaneously. Arterial
blood pressure, pulmonary artery (PA) pressure, body temperature,
oxygen saturation, arterial blood gases, and electrocardiographic
results were monitored and recorded. The PA catheter was with-
drawn during transplantation to permit clamping of and anastomo-
sis to the PA.
Donor Procedure
The donor operations were carried out according to established
clinical procedures used at our center for human transplantation.
The inferior vena cava (SVC) is incised initially to prevent right
heart dilatation during cardioplegia administration. Donor heart
preservation is done by instilling cardioplegic solution into the
aortic root (our institutional standard crystalloid cardioplegic so-
lution, containing 20 mEq KCl/L at 4°C) and topical hypothermia.
The venae cavae are transected. The aortic arch and PA are
transected. The pulmonary veins are then transected to complete
the explantation. The entire SVC, as well as the proximal portion
of the right subclavian vein (after ligation of the azygos vein), is
harvested to expedite the later right heart anastomosis. The as-
Figure 1. Schematic view of the isolated right heart remaining after excision of the LV. Note preservation of the
LAD. The PDA is also preserved (not shown). Note ligation of the coronary sinus. Also shown are the long stumps
preserved to facilitate later anastomoses: right PA, innominate and right subclavian veins, and entire aortic arch.
Note the hemostatatic over-and-over suture on the free edge of the former LV. Note that the aortic valve is exposed
on its inflow side to the pericardial space.
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cending aorta and aortic arch are harvested (after the great vessels
are divided) to facilitate the later aortic anastomosis. The left PA
of the donor is preserved maximally to optimize anatomic reach
for the later anastomosis.
Recipient Procedure
The recipient is cannulated through the right femoral artery and
vein for monitoring of the systemic arterial pressure and the PA
pressure. The right side of the chest is entered through a thoracot-
omy incision in the fourth intercostal space. The SVC is then
isolated, and vessel loops are placed for control. The right PA is
isolated likewise beyond the right middle lobe branch and within
the horizontal fissure.
Excision of the Donor Left Ventricle
Excision of the donor left ventricle (LV) is illustrated in Figure 1.
The donor’s LV is excised 1 cm beyond the interventricular groove
along the anterior wall just to the left of the left anterior descend-
ing coronary artery (LAD). Diagonal arteries are ligated according
to their size. The resultant incision is extended caudally around the
left ventricular apex to the inferior wall. Of note, the posterior
descending coronary artery is preserved, as well as the LAD. The
main trunk of the posterolateral branch of the right coronary artery
is divided as it runs laterally to the posterior surface of the LV in
the atrioventricular groove. The coronary sinus is also ligated. The
excision of the LV is then carried anteriorly across the left ven-
tricular outflow tract underneath the aortic valve. The left ventric-
ular excision is completed by incising the lateral wall of the LV
just caudal to the atrioventricular groove and the mitral valve
annulus. The circumflex artery is then ligated, along with the
marginal branches. Finally, the LV is removed from the operative
field once the chordal attachments are cut, thereby releasing the
LV with the papillary muscles still attached. The remaining cut
edge of the LV is then oversewn with a running over-and-over
suture, achieving complete hemostasis. As described, this method
preserves direct circulation to the right heart tissue through the
acute marginal branches of the right coronary artery, the posterior
descending artery and its septal perforating branches, and the LAD
and its septal perforating branches. The free wall of the left atrium
containing the pulmonary vein orifices is also excised. A patent
foramen ovale, if found, is closed.
Right PA Anastomosis
Right PA anastomosis is illustrated in Figure 2. Heparin (70 U/kg)
is administered intravenously before the first anastomosis. The
donor left PA is anastomosed end to side to the recipient’s right PA
Figure 2. PA anastomosis done in the fissure between lobes and performed in an end-to-side fashion.
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in a convenient location within the midportion of the horizontal
fissure. The anastomosis is carried out with a running 7-0 suture
after the proximal and distal control snares are tightened to allow
a relatively bloodless field. This anastomosis provides outflow
from the donor right heart.
SVC Anastomosis
SVC anastomosis is illustrated in Figure 3. The donor SVC is
anastomosed to the recipient’s SVC in an end-to-side fashion. A
side-biting clamp is used for SVC control. This anastomosis is
performed by using a 5-0 or 6-0 suture in a running fashion. This
anastomosis provides inflow to the donor right heart.
Aortic Anastomosis
Aortic anastomosis is illustrated in Figure 4. The donor aortic arch
is evaluated to determine which aortic branch (innominate, left
carotid, or left subclavian) will provide the best fit for a coronary
inflow anastomosis. This inflow anastomosis will provide only
coronary artery blood supply for the donor right heart. Once this
is decided, the other branches (remnants of the donor’s great
vessels) are closed with a running 5-0 suture. One of the
recipient’s great vessels, usually the left subclavian artery, is
borrowed to provide inflow to the coronary arteries of the donor
right heart. The recipient subclavian artery is clamped, divided,
and brought down for an end-to-end anastomosis to the selected
recipient aortic arch branch. This anastomosis is performed in
an end-to-end fashion. Once this anastomosis is completed, the
clamp on the subclavian artery is removed, and the donor’s
coronary arteries are perfused.
Topical hypothermia is used during the anastomosis process for
donor right heart preservation. The entire procedure is done with-
out cardiopulmonary bypass, with the donor heart beating and
providing circulation. A single dose of steroid medication (200 mg
of methoprednisolone; Solu-Medrol, Upjohn, Kalamazoo, Mich) is
given to prevent acute rejection. No other immunosuppressive
agents are used. The pulmonary anastomosis is released before the
SVC anastomosis to prevent distention of the donor right heart. An
epinephrine drip is started at 0.02 g · kg1 · min1 and titrated
to effect to stimulate the accessory right ventricle (RV) after the
ischemic interval (during preparation and implantation), as is our
practice in clinical transplantation.
At this point, the accessory right heart lies in the right side of
the chest (Figure 5) suspended by its vascular anastomoses. The
accessory right heart has, through these anastomoses, been con-
nected in parallel to the native right heart. This is shown schemat-
ically in Figures 5 and 6.
The animals were observed for 30 to 60 minutes, hemodynamic
measurements were taken, and the animals then euthanized. All
composite recipient-donor heart preparations were excised and
subjected to gross postmortem examination.
Figure 3. SVC anastomosis performed in an end-to-side fashion. Note that the azygos vein of the donor has
previously been ligated.
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Results
In all 4 animals receiving transplants, the accessory right
heart functioned well. The transplant procedure was able to
be successfully accomplished through a right-sided thora-
cotomy without cardiopulmonary bypass. The operation
proved technically feasible in all respects:
1. Excision of the LV. The donor LV was able to be
excised alone without any ill effects.
2. Prevention of bleeding. Septal wall bleeding, if any,
was minimal.
3. Preservation of coronary blood supply. Preservation
of coronary blood flow to the accessory RV was
successfully achieved, with a normal-appearing con-
traction pattern of the accessory RV.
4. Technical feasibility of anastomoses. All anastomoses
were constructed successfully and hemostatically. Sat-
isfactory reach and lie of all blood vessels was
achieved. With care to harvest generous portions of all
donor blood vessels, all anastomoses were well within
reach of their anatomic counterparts. No interposition
grafts proved necessary.
5. Thoracotomy approach. All anastomoses were able to
be accomplished outside of the pericardial sac.
6. Aortic valve competence. The donor aortic valve was
hemostatic. With this operation, the aortic valve be-
comes exposed to the pericardial space (after excision
of the LV). The aortic valve proved entirely hemo-
static. In some prior related animal experiments, we
closed the aortic valve surgically by suturing to sim-
ulate the clinical scenario. In patients the aortic valve
could not be relied on to prevent intrapericardial
bleeding without being surgically closed.
None of the recipients were started on cardiopulmonary
bypass. As in clinical transplantation, ventricular fibrillation
of the donor heart occurred early in the rewarming process
and responded to lidocaine administration, defibrillation, and
intermittent ventricular pacing. All animals required epineph-
rine for initial hemodynamic support. The systolic arterial
pressures ranged from 70 to 160 mm Hg, with a mean arterial
pressure of 85 mm Hg. All of the animals sustained adequate
hemodynamics with the accessory right heart online. In all
animals the donor heart beat vigorously, although not in syn-
chrony with the native heart. In one animal refractory fibrilla-
tion of the native right heart occurred several minutes after
successfully initiating function of the accessory right heart. The
accessory right heart was functioning well at that time.
Before the end point of the experiments, in 2 recipients
the native SVC was occluded (by a clamp proximal to the
end-to-side anastomosis of the donor heart), so as to obli-
gate upper body venous return to pass through the donor
right heart. Despite this occlusion, we observed preservation
of systemic blood pressure between 85 and 100 mm Hg.
There was no obvious evidence of donor right ventricular
strain under these circumstances.
Discussion
These experiments have shown that in the animal model
isolated transplantation of an auxiliary right heart is feasi-
ble. Hemostasis, coronary perfusion, and maintenance of
sinus rhythm proved feasible.
Patients who have a hypoplastic right heart or univen-
tricular heart have been palliated for many years with the
Glenn shunt or variations of the Fontan procedure, in which
the right heart is bypassed and the lungs are perfused by
venous pressure.3 Flow is surgically established from the
SVC, inferior vena cava, or right atrium directly into the
PAs. Although satisfactory palliation is often achieved for
years, many of these patients experience clinical deteriora-
tion over several decades because of arrhythmias, increasing
pulmonary vascular resistance (PVR), and ventricular fail-
ure.4 The experimental procedure described in this report
Figure 4. Arterial inflow anastomosis. The anastomosis is shown
here constructed between the left subclavian artery of the donor
(borrowed for use) and the left carotid branch of the donor aortic
arch. This anastomosis is performed in an end-to-side fashion.
The sole purpose is to provide inflow to the coronary arteries of
the donor right heart; any combination of aortic arch branches
can be used.
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could have clinical application for such patients. The acces-
sory right ventricular heart transplantation described in this
report permits ventricle-powered extra-anatomic lung per-
fusion.
Isolated right heart transplantation has several potential
advantages for this population compared with standard heart
transplantation. Many of these patients have a well-func-
tioning systemic ventricle, so that only the addition of a
pulmonary ventricle is truly required. The technique devel-
oped in the present series of experiments preserves the
well-functioning native systemic ventricle. Unlike conven-
tional heart transplantation, the systemic circulation is not
rendered subject to potential rejection of the systemic ven-
tricle. Rejection of an insolated accessory right heart would
be expected to have lesser clinical effect, allowing for a
larger margin of safety. Even in the case of rejection, the
accessory right heart should provide a passive conduit be-
tween the venous and pulmonary circulations. This novel
procedure is not intended for situations in which there is
accompanying recipient left heart dysfunction or severe
pulmonary hypertension, in which case standard orthotopic
or heterotopic transplantation might be necessary.
In terms of potential future candidate selection, the re-
cipient population for this procedure would not have pro-
hibitively high PVR, having already been palliated with the
Fontan circuit. A normally functioning accessory right heart
should be able to maintain good function in a setting of
normal or only moderately increased PVR. In addition, the
donor population for the procedure could be much larger
than the traditional donor pool. Many donor hearts with
decreased LV function might have well-functioning RVs
and thus would be donor candidates, even though their LVs
would be unsuitable for use in conventional heart transplan-
tation. Removal of the donor LV results in a transplanted
Figure 5. The completed operation. Note that the accessory right heart hugs the right border of the native heart but
lies in the right pleural space.
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organ with much smaller mass, facilitating implantation in
the right side of the chest without causing interference with
other vital thoracic organs.
Our previous studies have shown the feasibility of
separating the left and right sides of the heart.1,2 The
present investigation demonstrates a method for trans-
planting the isolated right heart with good immedi-
ate function. Multiple potential technical problems, in-
cluding achievement of adequate blood supply to the
isolated right heart and technical feasibility of anastomo-
ses, have been successfully overcome in this series of
experiments.
This was specifically a feasibility study. The animals
were euthanized approximately 1 hour after stable hemo-
dynamics were confirmed. These experiments were per-
formed on normal recipient animals without chronic con-
genital heart disease. Further studies are needed to detail
the physiologic relationship of the 2 RVs, including PA
pressures, blood flow in each of the 2 parallel right heart
circuits, and accessory right ventricular valvular func-
tion. Longer-term survival experiments are appropriate to
determine long-term function with 2 parallel right hearts.
Optimal synchronization of the 2 right hearts will need to
be explored, as has been done with heterotopic transplan-
tation. However, even without further refinement, in the
operation reported in this article, each ventricle is beating
synchronously with its own atrium.
This procedure is not intended to replace current surgical
therapy for infants and children with univentricular hearts
because current management is satisfactory without the
risks associated with immunosuppression and rejection.
Rather, we envision this procedure to have application to
older individuals with clinical deterioration late after initial
palliation with Glenn or Fontan procedures. Although con-
ventional reoperation on patients whose condition is dete-
riorating late after traditional univentricular heart proce-
dures produces some palliation,5 one could expect many
advantages from establishing a 2-ventricle system. These
advantages could be reflected in increased exercise capacity,
avoidance of arrhythmias, and prolongation of life expect-
ancy. A fully functioning right heart will likely decrease
central venous pressure, ameliorating right heart failure
associated with the passive Fontan flow and avoiding atrial
distention and its associated arrhythmias. The transplanted
right heart can be expected to accommodate over time to
overcome any modest increase in PVR, unlike the Fontan
circuit, in which a small increase in PVR can lead to
significant decompensation.
We believe that the novel accessory right heart trans-
plantation technique reported here might have application as
an alternate therapy to traditional heart transplantation for
the group of patients with longstanding univentricular phys-
iology with progressive circulatory dysfunction.
Figure 6. Schematic diagrams of resultant circulation. Note that the accessory right heart is connected in parallel
with the native right heart.
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